HIGHLIGHTS
- who: Li Wang from the Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, China have published the paper: Effect of ginsenoside compound K on alleviating colitis via modulating gut microbiota, in the Journal: Gut microbiota plays a vital role in maintaining body health [18]. Numerous studies have demonstrated that the gut microbiota is correlated to the occurrence and development of IBD [19], and the abundance and diversity of the gut microbiota of UC patients are decreased [20, 21]. Therefore, the regulation of gut microbiota has become a new therapeutic strategy of colitis. GC-K is . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.